Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study

doi:10.3748/wjg.v25.i40.6094

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 40

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6504)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

471

WORD

246

HTML

2966

Figures (1-3)

153

Tables (1-3)

153

Sum=3989

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

843

Download

1672

Sum=2515

Oct 28, 2019 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Oct 28, 2019; 25(40): 6094-6106
Published online Oct 28, 2019. doi: 10.3748/wjg.v25.i40.6094

Open in New Tab Full Size Figure Download Figure

Figure 1 Multi-state transition model. DAAs: Direct-acting antiviral agents; SVR: Sustained virologic response; HCC: Hepatocellular carcinoma.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan-Meier curves and risk table representing survival free of hepatocellular carcinoma or death from any cause according to sustained virologic response to hepatitis C virus direct-acting antiviral agents. Plain areas represent the 95% confidence interval. P value by the nonparametric log-rank test. SVR: Sustained virologic response; HCC: Hepatocellular carcinoma.

Open in New Tab Full Size Figure Download Figure

Figure 3 Kaplan-Meier curves and risk table representing survival free of hepatocellular carcinoma or death from any cause according to the presence of mixed cryoglobulinemia and sustained virologic response to hepatitis C virus direct-acting antiviral agents. P value by nonparametric log-rank test. +: with; -: without; MC: Mixed cryoglobulinemia; SVR: Sustained virologic response; HCC: Hepatocellular carcinoma.

Citation: Colussi G, Donnini D, Brizzi RF, Maier S, Valenti L, Catena C, Cavarape A, Sechi LA, Soardo G. Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study. World J Gastroenterol 2019; 25(40): 6094-6106
URL: https://www.wjgnet.com/1007-9327/full/v25/i40/6094.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i40.6094